Geneoscopy
Geneoscopy Gets Lab Permit From New York State Department of Health
With the New York lab permit, the St. Louis-based company can now offer its ColoSense colon cancer screening test throughout the US.
US Patent Trial and Appeal Board to Review Exact Sciences Patent Contested by Geneoscopy
The appeal board determined that Geneoscopy has a "reasonable likelihood" of proving at least one claim the company had alleged in requesting the review.
Geneoscopy Countersues Exact Sciences Over Patent Central to Cologuard
Geneoscopy alleges that Exact Sciences has misappropriated its trade secrets, breached contract, and engaged in unfair competition.
Exact Sciences May Proceed With Patent Suit Against Geneoscopy, Court Rules
Exact Sciences alleges that Geneoscopy's ColoSense assay infringes upon patents covering Exact's Cologuard colorectal cancer assay.
Geneoscopy Nabs FDA Approval for Stool-Based Colorectal Cancer Screening Test
The St. Louis company's ColoSense assay is likely going to compete with Exact Sciences' Cologuard CRC screening test.